Aim: Autologous fat grafting has gained acceptance as a technique to improve aesthetic outcomes in breast reconstruction. The purpose of this study was to share our clinical experience using autologous fat injection to correct contour deformities during breast reconstruction. Methods: A single surgeon, prospectively maintained database of patients who underwent autologous fat injection during breast reconstruction from January 2008 to November 2013 at McGill University Health Center was reviewed. Patient characteristics, breast history, type of breast reconstruction, volume of fat injected, and complications were analyzed. Results: One hundred and twenty-four patients benefited from autologous fat injection from January 2008 to November 2013, for a total of 187 treated breasts. The patients were on average 49.3 years old (± 8.9 years). Fat was harvested from the medial thighs (20.5%), flanks (39.1%), medial thighs and flanks (2.9%), trochanters (13.3%), medial knees (2.7%), and abdomen (21.9%). An average of 49.25 mL of fat was injected into each reconstructed breast. A total of 187 breasts in 124 patients were lipo-infiltrated during the second stage of breast reconstruction. Thirteen breasts (in 12 separate patients) were injected several years after having undergone lumpectomy and radiotherapy. Of the 187 treated breasts, 118 were reconstructed with expanders to implants, 45 with deep inferior epigastric perforator flaps, 9 with latissimus dorsi flaps with implants, 4 with transverse rectus abdominis myocutaneous flaps, and 13 had previously undergone lumpectomy and radiotherapy. Six complications were noted in the entire series, for a rate of 3.2%. All were in previously radiated breasts. Average follow-up time was 12 months (range: 2-36 months). Conclusion: Fat injection continues to grow in popularity as an adjunct to breast reconstruction. Our experience demonstrates a low complication rate as compared to most surgical interventions of the breast and further supports its safety in breast reconstruction. However, caution should be used when treating previously radiated breasts.
INTRODUCTION
Fat injection is a useful surgical modality to correct anatomic contour deformities. [1] [2] [3] In 1987, the American Society of Plastic Surgeons published a report discouraging the use of autologous fat injections in the breast due to potential complications related to calcifications and detection of breast cancer. [4] Improvements and technique have since enhanced the clinical utility of fat grafting, and autologous fat injection is now commonly used to correct breast defects. [5, 6] To date, retrospective studies have shown that complications associated with fat injection markedly decreased with the evolution of fat grafting protocols. [7, 8] Calcification and fat necrosis have been shown to correlate with the volume, as well as the technique of fat injection. [9] [10] [11] There is also evidence that the volume injected correlates with survival of the grafted fat. [12] The minimally invasive nature of the procedure allows patients to benefit from autologous tissue rather than foreign materials. As such, fat grafting has evolved into a safe procedure to correct contour deformities in the reconstructed breast. [7] Although some controversy remains with regards to the benefits and risks of autologous fat injections, it is widely used by reconstructive plastic surgeons to correct contour deformities in breast reconstruction. [6] Our experience suggests this is a safe procedure that provides significant improvement to breast contour following reconstruction. This study describes a Karl Schwarz (KS) experience with fat injection to correct contour deformities during breast reconstruction.
METHODS

Patient population
The present study was approved by the McGill University Health Centre Ethics Board. A Karl Schwarz (KS), prospectively maintained database of patients who underwent autologous fat injection during breast reconstruction from January 2008 to November 2013 at McGill University Health Center was reviewed. Patient characteristics, breast history, type of breast reconstruction, volume of fat injected, and complications were analyzed retrospectively.
Technique
Autologous fat was harvested using previously described techniques. [13] Donor sites included medial thighs, flanks, trochanters, arms, or abdominal subcutaneous fat. Under sterile conditions, fat was harvested using the Tulip liposuction system (Tulip Medical Products, San Diego, CA) with a 3 mm cannula. No donor site morbidity was observed in any of the patients enrolled in this study. The fat was then purified on large Telfa Pads (Covidien, Mansfield, MA) as previously described by Kanchwala et al. [13] Once the fat reached a custard-like consistency, it was loaded into 10-mL syringes [ Figure 1 ]. Based on preoperative topographic markings, fat was then injected into the breasts in 1 mL aliquots, distributing it evenly in multiple tissue planes, using multiple passes, to visibly correct the previously present contour deformity [ Figure 2 ].
Review of the literature
As a measure of comparison with previously published studies, we conducted a literature search of the PubMed database using the keywords "fat graft breast" in PubMed. Our search yielded 149 articles, of which 12 met our inclusion criteria requiring that the studies enroll at least 10 patients, measure fat grafting in a clinical context, and include outcomes and complications [ Table 1 ].
RESULTS
One hundred and twenty-four patients benefited from autologous fat injection from January 2008 to November 2013, for a total of 187 treated breasts. The patients were on average 49.3 years old (± 8.9 years). Fat was most often harvested from the medial thighs (20.5%), flanks (39.1%), medial thighs and flanks (2.9%), trochanters (13.3%), medial knees (2.7%), and abdomen (21.9%). An average of 49.25 mL (ranging from 8 to 210 mL) of fat was injected into each reconstructed breast [ Table 2 ].
A total of 174 breasts in 112 patients were injected with autologous fat during the second stage of breast reconstruction. Thirteen breasts (in 12 separate patients) were injected after having undergone lumpectomy and radiotherapy. Eight breasts (in 5 separate patients) underwent a second round of fat injection 6 months after the initial lipoinjection. Of the 187 treated breasts, 118 were reconstructed with expanders to implants, 45 with deep inferior epigastric perforator (DIEP) flaps, 9 with latissimus dorsi flaps with implants, 4 with transverse rectus abdominis myocutaneous flaps [ Table 3 ]. Thirteen of the breasts had previously undergone lumpectomy and radiotherapy. Representative images of patients treated with autologous fat grafting are shown in Figures 3 and 4 .
Six complications in 3 separate patients were noted in the entire series, for a rate of 3.2%. All were in previously radiated breasts. One patient developed an isolated area of fat necrosis but also an occult pneumothorax treated conservatively. One patient developed a cellulitis treated successfully with antibiotics, and another patient developed an infection that was drained with a pig-tail catheter. Oil cysts were noted in 3 breasts.
DISCUSSION
Our experience suggests that autologous fat injection is a safe and effective procedure for correcting contour deformities following breast reconstruction. Of the 187 treated breasts in our study, we identified complications in only 6 patients for a complication rate of 3.2%. It should be noted that each of these complications occurred in previously irradiated breasts, which have been associated with impaired healing secondary due to radiation damage. [5] Although our reported rates of fat necrosis and oil cysts are low in nonradiated breasts, it must be noted that they only represent those discovered on physical exam. It is likely that radiographic evaluation would yield higher rates.
Assessment of the literature and the data presented in this article suggest that fat injection can be a safe procedure. Although the studies reviewed demonstrate significant variability among complication rates, our 6 complications in 187 treated breasts lies on the lower end of the spectrum. 
Average volume of fat injection (mL) Complications
Pérez-Cano et al. [20] 2012 71 140 14.1% of patients developed cysts Khouri et al. [21] 2012 81 277 16% of patients report fat necrosis after 1-year Rubin et al. [22] 2012 27 526.5 25.5% of patients developed oil cysts 17.1% of patients developed fat necrosis De Blacam et al. [23] 2011 49 67 3.6% of patients developed fat necrosis 1.8% of patients developed oil cysts 0.9% of patients developed infections Kijima et al. [24] 2012 21 123 4.7% of patients developed fat necrosis 4.7% of patients developed infection Kamakura and Ito [25] 2011 20 240 11% of patients developed oil cysts Losken et al. [26] 2011 107 40 11% of patients reported fat necrosis, erythema, keloid scarring, and pain Serra-Renom et al. [27] 2011 28 39.36 0% fat stable in all patients Sinna et al. [28] 2010 244 176 2% of patients developed fat necrosis 1.2% of patients developed infection Yoshimura et al. [29] 2010 15 264 0% no reported complications Illouz and Sterodimas [30] 2009 820 145 9.2% of patients developed bruising 4.3% of patients developed striae 1.4% of patients developed hematomas 0.6% of patients developed infections Panettiere et al. [31] 2009 61 24.5 0% no reported complications
Despite having experienced few complications, all patients with a suspicious lesion or nodule were encouraged to follow-up with their breast surgeon and oncologist. [8, 11] Fortunately, radiographic evaluation can reliably distinguish calcifications, fat necrosis and oil cysts from malignant lesions. [4] The complications identified in our patients occurred only in radiated breasts. Despite the paucity of data regarding fat injection in radiated breasts, there is evidence demonstrating the success of fat injection into radiated tissue. [14] While prior radiation may be a risk factor for fat necrosis, it appears that lipoinjection alleviates the damage associated with radiation. [15, 16] Clearly, further studies are needed to elucidate the advantages and pitfalls of fat injection in radiated breasts.
It is important to point out that familiarity with the technical aspects of fat injection affects the incidence of complications. [7, 8] While the incidence of fat necrosis and graft resorption is reduced when small aliquots are injected in multiple tissue planes, there is evidence that the long-term viability is increased with greater overall injection volumes. [10, 12, 17] A discussion on the safety of fat injection would not be complete without addressing the potential effects of lipoinjection on local breast cancer recurrence. The increase in vascularity promoted by injected adipose tissue may present a theoretical risk for recurrence. [17] A study by Petit et al. [18, 19] describes early follow-up data suggesting that fat grafting does not present an increased risk for cancer recurrence, however, a follow-up cohort study by the same author suggests that the risk for recurrence could increase in women with high-grade intraepithelial neoplasia under the age of 50. An additional study funded by The Plastic Surgery Foundation is ongoing to further evaluate the oncologic safety of fat grafting in breast cancer patients.
In conclusion, contour irregularities are common problems associated with breast reconstruction and can lead to suboptimal cosmetic results. Fat injection is a powerful tool that provides surgeons the ability to achieve esthetically superior results. Meticulous technique and proper planning, particularly assessing the recipient site and limiting injection volumes, allows surgeons to deliver results with low complication rates. 
